Eden Prairie, MN – According to filings with the U.S. Securities and Exchange Commission, RxFunction is raising $8,087,507.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Mary Anderson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About RxFunction

RxFunction is a wearable medical device company with an initial focus on developing and leading a new business segment within the U.S.  The company’s first product is Walkasins – a wearable lower limb sensory neuroprosthesis. Walkasins aid in balance and functional gait improvement, enabling physicians to prescribe it for patients suffering from balance problems due to peripheral neuropathy. Privately held and headquartered outside of Minneapolis, MN, RxFunction has taken assignment of patented technology developed by Co-founder, Dr. Lars Oddsson, as a research professor at Boston University’s Neuromuscular Research Center. RxFunction is privately funded and has been supported by an SBIR grant from the NIH’s National Institute on Aging.

To learn more about RxFunction, visit http://rxfunction.com/

Contact:
Mary Anderson, Chief Financial Officer
612-800-9950
mary.anderson@rxfunction.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved